Skip to search formSkip to main contentSkip to account menu

dexmethylphenidate hydrochloride

Known as: Dexmethylphenidate Hydrochloride [Chemical/Ingredient], d-threo-Methylphenidate Hydrochloride, 2-Piperidineacetic Acid, Alpha-phenyl-, Methyl Ester, Hydrochloride, (alphaR,2R)- 
A synthetic sympathomimetic amine with CNS stimulating properties. Dexmethylphenidate hydrochloride acts by facilitating the release of… 
National Institutes of Health

Related topics

Related topics

20 relations
24 HR dexmethylphenidate hydrochloride 30 MG Extended Release Oral CapsuleAnxiety DisordersAttention deficit hyperactivity disorderBehavioral tic

Broader (3)

Central Nervous System StimulantsDopamine Uptake Inhibitorsdexmethylphenidate

Narrower (2)

FocalinFocalin XR

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder
2014
2014
Efficient method for enantioselective synthesis of dexmethylphenidate hydrochloride (focalin
An improved economical and eco friendly process for the enantioselective resolution of methylphenidate free base to give (2R,2’R… 
2009
2009
Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder.
OBJECTIVE This 5-week, multicenter, double-blind, placebo-controlled, parallel-group investigation is the first fixed-dose study… 
Highly Cited
2008
Highly Cited
2008
Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
BACKGROUND Fatigue is a common complaint in patients with sarcoidosis. We studied the effectiveness of dexmethylphenidate… 
Review
2006
Review
2006
Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder
Attention-deficit/hyperactivity disorder (ADHD) affects a large number of children. For decades, the stimulants have been the… 
2005
2005
Focalin TM XR ( dexmethylphenidate hydrochloride ) extended-release capsules
FocalinTM XR (dexmethylphenidate hydrochloride) extended-release capsules is an extended-release formulation of… 
2004
2004
A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.
OBJECTIVES d,l-threo-methylphenidate HCl (D,L-MPH) is the most common treatment of attention deficit hyperactivity disorder (ADHD… 
2004
2004
A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).
OBJECTIVE To evaluate clinical measures of the benefit/risk ratio in a post hoc analysis of a clinical trial of d-threo… 
2004
2004
Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder.
BACKGROUND This pilot study examined the efficacy and duration of the effect of dexmethylphenidate (d-MPH) given once-daily in… 
2004
2004
A Single‐Dose, Two‐Way Crossover, Bioequivalence Study of Dexmethylphenidate HCl with and without Food in Healthy Subjects
Attention deficit hyperactivity disorder (ADHD) in children is effectively treated by racemic oral methylphenidate (dl‐MPH). The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)